Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioceres Crop Solutions (BIOX) Goodwill (2017 - 2026)

Bioceres Crop Solutions' Goodwill history spans 10 years, with the latest figure at $36.1 million for Q1 2026.

  • On a quarterly basis, Goodwill changed N/A to $36.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $36.1 million, a N/A change, with the full-year FY2025 number at $112.2 million, changed 0.03% from a year prior.
  • Goodwill hit $36.1 million in Q1 2026 for Bioceres Crop Solutions, down from $112.2 million in the prior quarter.
  • Over the last five years, Goodwill for BIOX hit a ceiling of $112.2 million in Q2 2025 and a floor of $36.1 million in Q2 2022.
  • Historically, Goodwill has averaged $81.7 million across 5 years, with a median of $112.2 million in 2023.
  • Biggest five-year swings in Goodwill: surged 210.93% in 2023 and later changed 0.0% in 2024.
  • Tracing BIOX's Goodwill over 5 years: stood at $36.1 million in 2022, then surged by 210.93% to $112.2 million in 2023, then changed by 0.0% to $112.2 million in 2024, then rose by 0.03% to $112.2 million in 2025, then crashed by 67.83% to $36.1 million in 2026.
  • Business Quant data shows Goodwill for BIOX at $36.1 million in Q1 2026, $112.2 million in Q2 2025, and $112.2 million in Q2 2024.